Biopharmaca BiofarmakaPT. Primax & BRC Developing Raw Material of Pangolin

PT. PRIMAX & BRC DEVELOPING RAW MATERIAL OF PANGOLIN

Pusat Studi Biofarmaka

On Thursday (27/1), located at Ruang Sidang LPPM-IPB, Gedung Andi Hakim Nasoetion Floor 3rd Kampus IPB Darmaga, Biopharmaca Research Center (BRC), which represented by the Head of Research & Community Services Institute (LPPM-IPB) signed an Mou with PT. Primax Asia Link in order to Research, Developing, Breeding, Cultivation of Pangolin. The MoU has period of five years.

MoU Trenggiling

Chief of Operating Officer PT. Primax, Mr. Beni Soesanto, said that many researches in China using pangoling of Chuan Shan Jia (Chinese language) as medicine. This year, the activity will be started with a workshop, and the next step will be research for efficacy and breeding of pangolin.

Head of LPPM-IPB, Prof. Dr. Ir. Bambang Pramudya N, M. Eng, supported this effort in developing Indonesian resources, which a lot of them are not utilized and the activity can be sustainable. Meanwhile, Head of BRC, Prof. Latifah K Darusman, said that the activity is part of multidicipline cooperation, both in biopharmaca resource (animal) and efficacy & developing of product. The research of biopharmaca utilization of pangolin can be expected as raw material for herb/jamu. Additionally, BRC has developed product from worm, while from medicinal plant has been relatively more developed. The workshop about pangolin potency will plan in March 2011.

<ta>
Back to BRC Home....